Skip to main content

Logo
  • Live News iconLive News
  • Smart Screener iconSmart Screener
  • Trade Opportunities iconTrade Opportunities
  • Alpha Watch iconAlpha Watch
  • Catalyst iconCatalyst
Skip to main content
Stock Ask Logo
Hi, Guest User

Log in or create an account to get full access

Open an Account (opens in a new window)

TOOLS

Live News
Smart Screener
Trade Opportunities
Alpha Watch
Catalyst

StockkASK powered by Indira Securities

Bharat Parenterals Ltd (BPLPHARMA) Share Price & Fundamentals

SegmentOfferingsAdvantages / MoatCustomersHigh-Margin AreasRevenue (₹ Cr.)Revenue %How We EarnPricing ModelGrowth DriversTop Brands
Standalone Pharmaceutical ManufacturingManufacture of finished dosage pharmaceutical products including injectables, tablets, capsules for India and export.WHO and USFDA-approved facilities with established institutional client base and quality certifications.Hospitals, healthcare institutions, distributors in India and select emerging markets.Specialty injectables and critical care formulations.31893Direct sales and B2B contracts with hospitals and distributors.Direct sales with negotiated pricing for institutional buyers.Regulatory approvals, product registrations, and expanding Indian and emerging market reach.Institutional anesthesia and critical care injectables; life-saving drugs; generic formulations.
Innoxel Lifesciences (Subsidiary) - Regulated Market CDMODevelopment and contract manufacturing of complex formulations for regulated markets US and EU.Regulatory approved specialty facilities and strong R&D team with patent portfolios.Large generic and innovator pharma companies in US and Europe.Proprietary specialty generics and niche formulation platforms.407Milestone payments, manufacturing service revenue, profit sharing with front-end marketing partners.Contract manufacturing and licensing revenue with milestone-linked payments.EU GMP and USFDA approval, new product launches, and strategic licensing deals.Complex specialty generics including liposomal injectables, extended release injectables, oncology oral liquids.
Varenyam Healthcare (Subsidiary) - Branded Generics IndiaBranded specialty generic pharmaceuticals targeting institutional markets in India.Strong hospital relationships and synergy with parent manufacturing capabilities.Institutional hospitals and healthcare providers in India.Newer specialty injectable formulations.6017Sales via field force targeting top hospital chains across India.Direct sales through on-ground representative network.Portfolio expansion, hospital presence, and product innovation in anesthesia and critical care.Anesthesia reversal Sugammadex, pain management injectables.

StockkASK provides smart, AI-powered insights to support analysis. AI can make mistakes; verify independently before investing.Terms & Conditions